Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement

Détails

Ressource 1Télécharger: REF.pdf (184.41 [Ko])
Etat: Public
Version: Final published version
Licence: Non spécifiée
It was possible to publish this article open access thanks to a Swiss National Licence with the publisher.
ID Serval
serval:BIB_A90C1B92E906
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement
Périodique
Brain : A Journal of Neurology
Auteur⸱e⸱s
Bien C.G., Granata T., Antozzi C., Cross J.H., Dulac O., Kurthen M., Lassmann H., Mantegazza R., Villemure J.G., Spreafico R., Elger C.E.
ISSN
1460-2156 (Electronic)
ISSN-L
0006-8950
Statut éditorial
Publié
Date de publication
2005
Volume
128
Numéro
Pt 3
Pages
454-471
Langue
anglais
Notes
Publication types: Consensus Development Conference ; Journal Article ; Review
Publication Status: ppublish
Résumé
Rasmussen encephalitis (RE) is a rare but severe immune-mediated brain disorder leading to unilateral hemispheric atrophy, associated progressive neurological dysfunction and intractable seizures. Recent data on the pathogenesis of the disease, its clinical and paraclinical presentation, and therapeutic approaches are summarized. Based on these data, we propose formal diagnostic criteria and a therapeutic pathway for the management of RE patients.
Mots-clé
Anticonvulsants/therapeutic use, Encephalitis/diagnosis, Encephalitis/etiology, Encephalitis/immunology, Encephalitis/therapy, Epilepsy/etiology, Immunotherapy/methods, T-Lymphocytes, Cytotoxic/immunology
Pubmed
Web of science
Open Access
Oui
Création de la notice
13/07/2018 9:00
Dernière modification de la notice
14/02/2022 7:56
Données d'usage